These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 36765502)

  • 41. Laboratory assays for predicting the severity of haemolytic disease of the fetus and newborn.
    Hadley AG
    Transpl Immunol; 2002 Aug; 10(2-3):191-8. PubMed ID: 12216949
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of red blood cell antibodies in maternal breast milk implicated in prolonged hemolytic disease of the fetus and newborn.
    Leonard A; Hittson Boal L; Pary P; Mo YD; Jacquot C; Luban NL; Darbari DS; Webb J
    Transfusion; 2019 Apr; 59(4):1183-1189. PubMed ID: 30720868
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hemolytic disease of the fetus and newborn with late-onset anemia due to anti-M: a case report and review of the Japanese literature.
    Yasuda H; Ohto H; Nollet KE; Kawabata K; Saito S; Yagi Y; Negishi Y; Ishida A
    Transfus Med Rev; 2014 Jan; 28(1):1-6. PubMed ID: 24262303
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Direct antiglobulin test in the differential diagnosis of ABO hemolytic disease of the newborn: an important tool with high negative predictive value.
    Abbas SA; Dinardo CL; Godinho CH; Ziza K; Cruz B; Martins JO; Moritz E; Langui DM; Bordin JO
    Hematol Transfus Cell Ther; 2024 Apr; ():. PubMed ID: 38719716
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevalence and Specificity of Red Blood Cell Alloantibodies in Patients from China During 1994-2013.
    Yu Y; Wang Y; Sun XL; Ma CY; Zhang XJ; Guan XZ; Chen LF; Wang DQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Dec; 23(6):1734-41. PubMed ID: 26708902
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hemolytic Disease of the Fetus and Newborn Caused by Maternal Autoantibody with Mimicking Anti-E Specificity.
    Chen X; Feng J; Jiang Y
    Lab Med; 2021 Jul; 52(4):399-402. PubMed ID: 33219819
    [TBL] [Abstract][Full Text] [Related]  

  • 47. ABO BLOOD GROUP SYSTEM AND ITS RELATIONSHIP TO HEMOLYTIC DISEASE.
    FREDA VJ; CARTER BA
    Clin Obstet Gynecol; 1964 Dec; 10():968-84. PubMed ID: 14234049
    [No Abstract]   [Full Text] [Related]  

  • 48. Risk of maternal alloimmunization in Southern Pakistan - a study in a cohort of 1000 pregnant women.
    Karim F; Moiz B; Kamran N
    Transfus Apher Sci; 2015 Feb; 52(1):99-102. PubMed ID: 25532481
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diagnostic laboratory technologies for the fetus and neonate with isoimmunization.
    Geaghan SM
    Semin Perinatol; 2011 Jun; 35(3):148-54. PubMed ID: 21641488
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Alloimmune hemolytic disease of the fetus and newborn: genetics, structure, and function of the commonly involved erythrocyte antigens.
    Christensen RD; Bahr TM; Ilstrup SJ; Dizon-Townson DS
    J Perinatol; 2023 Dec; 43(12):1459-1467. PubMed ID: 37848604
    [TBL] [Abstract][Full Text] [Related]  

  • 51. ABO incompatibility and RhIG immunoprophylaxis protect against non-D alloimmunization by pregnancy.
    Zwiers C; Koelewijn JM; Vermij L; van Sambeeck J; Oepkes D; de Haas M; van der Schoot CE
    Transfusion; 2018 Jul; 58(7):1611-1617. PubMed ID: 29624682
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hemolytic Disease of Fetus and Newborn in a Primigravida with Multiple Alloantibodies Involving Anti-Jk
    Iberahim S; Aizuddin MJ; Kadir NA; Rameli N; Adzahar S; Noor NHM; Abdullah WZ
    Oman Med J; 2020 Nov; 35(6):e206. PubMed ID: 33335745
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hemolytic disease of the fetus and newborn: systematic literature review of the antenatal landscape.
    de Winter DP; Kaminski A; Tjoa ML; Oepkes D
    BMC Pregnancy Childbirth; 2023 Jan; 23(1):12. PubMed ID: 36611144
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fatal hemolytic disease of the fetus and newborn caused by anti-Jr
    Kim MS; Kim JS; Park H; Chung Y; Kim H; Ko DH; Hwang SH; Won HS; Oh HB
    Transfus Apher Sci; 2020 Feb; 59(1):102605. PubMed ID: 31324575
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Severe hemolytic disease of the newborn in a group B African-American infant delivered by a group O mother.
    Drabik-Clary K; Reddy VV; Benjamin WH; Boctor FN
    Ann Clin Lab Sci; 2006; 36(2):205-7. PubMed ID: 16682519
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Third trimester screening for alloimmunisation in Rhc-negative pregnant women: evaluation of the Dutch national screening programme.
    Slootweg YM; Koelewijn JM; van Kamp IL; van der Bom JG; Oepkes D; de Haas M
    BJOG; 2016 May; 123(6):955-63. PubMed ID: 26661943
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of the Detection Rate and Specificity of Irregular Red Blood Cell Antibodies Between First-Time Pregnant Women and Women With a History of Multiple Pregnancies Among 18,010 Chinese Women.
    Wu S; Wu Y; Guo G; Xie R; Wu Y
    J Pregnancy; 2024; 2024():5539776. PubMed ID: 38883212
    [No Abstract]   [Full Text] [Related]  

  • 58. Impact of red blood cell alloimmunization on fetal and neonatal outcomes: A single center cohort study.
    Lieberman L; Callum J; Cohen R; Cserti-Gazdewich C; Ladhani NNN; Buckstein J; Pendergrast J; Lin Y
    Transfusion; 2020 Nov; 60(11):2537-2546. PubMed ID: 32893897
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular characterization and multidisciplinary management of Gerbich hemolytic disease of the newborn.
    Levitt RN; Gourri E; Gassner C; Banez-Sese G; Salam A; Denomme GA; Yang E
    Pediatr Blood Cancer; 2018 Jun; 65(6):e27014. PubMed ID: 29469208
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A case report of haemolytic disease of the foetus and newborn caused by Alloantibody D and Jka in a Rhesus D negative Nigerian woman: Justification for the implementation of universal access to prophylaxis and evidenced-based best practices.
    Erhabor O; Azachi WB; Tosan E
    Hum Antibodies; 2020; 28(3):245-252. PubMed ID: 32417769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.